Home > Financial Ratios > NEULAND LABORATORIES

NEULAND LABORATORIES
Fixed Capital/Sales

    Back to All Ratios
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Fixed Capital/Sales(x) 0.780.910.820.850.79

What is the latest Fixed Capital/Sales ratio of NEULAND LABORATORIES ?

The latest Fixed Capital/Sales ratio of NEULAND LABORATORIES is 0.78 based on Mar2023 Consolidated results.
Year Fixed Capital/Sales
Mar20230.78
Mar20220.91
Mar20210.82
Mar20200.85
Mar20190.79

How is Fixed Capital/Sales of NEULAND LABORATORIES Trending?

Years Fixed Capital/Sales % Change
Mar2023 0.78
-14.29
Mar2022 0.91
10.98
Mar2021 0.82
-3.53
Mar2020 0.85
7.59
Mar2019 0.79 -

Other Financial Ratios of NEULAND LABORATORIES


Compare Fixed Capital/Sales ratio of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹9,806.5 Cr 7.6% 22% 261.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹364,315.0 Cr -0.1% -6.3% 53.5% Stock Analytics
CIPLA ₹114,614.0 Cr 1% -5% 53.3% Stock Analytics
DIVIS LABORATORIES ₹105,233.0 Cr 3.2% 15.3% 23.6% Stock Analytics
DR REDDYS LABORATORIES ₹104,900.0 Cr 1.1% 2.2% 26% Stock Analytics
ZYDUS LIFESCIENCES ₹99,426.0 Cr 3.9% -1.7% 85.2% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

7.6%

22%

261.3%

SENSEX

1%

2.2%

23.7%


You may also like the below Video Courses